Complicated Silicosis
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Pirfenidone for the Reduction of Metabolic, Inflammatory and Fibrogenic Activity in Complicated Silicosis (NCT05118256) | Instituto de investigación e innovación biomédica de Cádiz | 2021-11-15 |
Track Complicated Silicosis automatically
Every clearance here is in the API, with alerts when new ones post.